About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Alcobra Pharma Announces Fourth Quarter and Fiscal Year 2014 Financial Results

by Vishnuprasad on February 17, 2015 at 6:45 PM
Font : A-A+

Alcobra Pharma Announces Fourth Quarter and Fiscal Year 2014 Financial Results

Alcobra Pharma, an emerging company focused on the development of new medications to help patients with cognitive disorders, has announced financial results for the fourth quarter and fiscal year ended December 31, 2014, and provided a business update.

The company reported ($0.50) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.57) by $0.07. They set a 'buy' rating and a $10.00 price target on the stock. Analysts at Zacks downgraded shares of Alcobra from an 'outperform' rating to a 'neutral' rating and set a $3.90 price target on the stock in a research note on Wednesday, November 26th.

Advertisement

Finally, analysts at Aegis downgraded shares of Alcobra from a 'buy' rating to a "hold" rating in a research note on Monday, November 17th. Five equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. The company currently has an average rating of 'Hold' and a consensus target price of $17.56.



Source: Medindia
Advertisement
Advertisement
Advertisement

Recommended Reading

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Alcobra Pharma Announces Fourth Quarter and Fiscal Year 2014 Financial Results Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests